NexGard Combo is broadly considered safe for cats when used according to its label. Across multiple manufacturer-sponsored safety studies, researchers found no significant treatment-related adverse effects at normal doses, and field trials comparing it to an established competitor reported zero adverse reactions in treated cats. That said, “safe” in veterinary medicine never means “zero risk for every cat.” A small number of cats can experience side effects, and certain genetic conditions can dramatically change how a cat handles one of the product’s ingredients. Understanding those edge cases matters more than the overall safety verdict.
What NexGard Combo Actually Contains
NexGard Combo is a spot-on (topical) formulation that combines three active ingredients: esafoxolaner, eprinomectin, and praziquantel. Each one targets a different category of parasite, which is why the product is marketed as a broad-spectrum treatment covering fleas, ticks, mites, roundworms, hookworms, tapeworms, and heartworm prevention all in a single monthly application.1PubMed Central. NexGard Combo (esafoxolaner, eprinomectin, praziquantel), a new endectoparasiticide spot-on formulation for cats
Esafoxolaner is the flea-and-tick ingredient. It belongs to the isoxazoline class, the same drug family found in other popular parasite preventatives for dogs and cats. Specifically, esafoxolaner is a purified version (a single enantiomer) of afoxolaner, which has been used in canine products for years.2PubMed Central. Pharmacokinetics of a novel endectoparasiticide topical formulation for cats, combining esafoxolaner, eprinomectin and praziquantel Eprinomectin handles internal parasites like roundworms and hookworms and also provides heartworm prevention. Praziquantel targets tapeworms. The three-in-one design is the product’s main selling point: one tube on the back of the neck replaces what might otherwise be two or three separate products.
What the Safety Studies Found at Normal Doses
The formal safety evaluation for NexGard Combo involved three studies testing the product at one, three, and five times the recommended dose, administered repeatedly. At the standard label dose, and even at three times that dose, no significant treatment-related effects were observed.3PubMed Central. Target animal safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for cats A separate heartworm-prevention study similarly concluded that the product at its minimum label dose was “well-tolerated,” with no adverse reactions linked to treatment.4PubMed Central. Efficacy of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for the prevention of heartworm disease in cats
In a field study that pitted NexGard Combo against Frontline Combo for treating cat lice, none of the 14 cats in the NexGard Combo group showed any adverse reactions over 30 days of monitoring.5PubMed Central. Efficacy of a topical formulation containing esafoxolaner, eprinomectin and praziquantel (NexGard Combo®) against natural infestations with the cat louse, Felicola subrostratus under field conditions The overall picture from these controlled studies is reassuring: for a typical healthy cat receiving the correct dose, the product has a clean safety record in the published literature.
That does not mean your cat will definitely have no reaction. Mild, transient skin irritation at the application site is a possibility with any topical product. Some cats may drool or show brief discomfort if they manage to lick the application area before it dries. These reactions, while not prominently flagged in the formal studies, are common enough with spot-on treatments in general that they are worth mentioning.
The One Neurological Event That Showed Up
The most notable finding from the safety studies was a single occurrence of reversible neurological signs in one cat, and even that happened under extreme dosing conditions. In the overdose study, one cat developed neurological symptoms after receiving the third application of five times the normal dose. The signs appeared about nine hours after dosing, were most pronounced for a few hours, improved significantly by the next day, and were completely gone within two days. Researchers attributed the episode to the eprinomectin component.3PubMed Central. Target animal safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel for cats
This is worth putting in perspective. The cat received five times the normal dose three times in a row. No cat receiving the label dose or even three times the label dose in these studies showed neurological signs. The episode resolved completely within 48 hours. So while the possibility of neurological effects exists in the product’s safety profile, it took a dramatic overdose to trigger it in the study setting.
Isoxazolines and Neurological Risk in the Real World
Esafoxolaner belongs to the isoxazoline drug class, which works by blocking nerve signaling in parasites. Because the mechanism targets the nervous system of insects and arachnids, regulators and researchers have been attentive to whether these drugs can occasionally affect the nervous systems of the animals they are applied to. Across all isoxazoline products used in cats and dogs, neurological adverse events are rarely reported, though when they do occur, the details about how quickly signs appear and how long they last have been limited in official product documentation.6Veterinary Record. Neurological adverse effects of isoxazoline exposure in cats and dogs
Reported neurological signs with isoxazolines in general can include muscle tremors, unsteadiness, and in rare cases seizures. The U.S. Food and Drug Administration added a class-wide warning to isoxazoline products in 2018, advising caution in animals with a history of seizures or neurological disorders. This warning applies to NexGard Combo as well. If your cat has ever had seizures or has a known neurological condition, you should discuss the risks with your veterinarian before starting this or any isoxazoline-based product.
The rarity of these events makes them difficult to study systematically. Most veterinarians regard isoxazolines as having a strong safety profile overall, and millions of doses are administered each year. But the rare cat that does react can have a frightening episode, so the risk is not theoretical. If you notice wobbliness, twitching, or unusual behavior within hours of applying NexGard Combo, contact your veterinarian.
The P-Glycoprotein Problem and ABCB1 Mutations
This is the most important hidden risk that most cat owners have never heard of. Some cats carry a mutation in a gene called ABCB1, which codes for a protein called P-glycoprotein. P-glycoprotein acts as a pump in cells, particularly at the blood-brain barrier, pushing certain drugs back out of the brain before they can accumulate to harmful levels. Cats with two copies of a specific ABCB1 mutation (homozygous for ABCB1 1930_1931del TC) have a non-functional version of this pump, meaning drugs that rely on P-glycoprotein clearance can build up in the brain and cause toxicity.7Journal of Feline Medicine and Surgery Open Reports. Inherent P-glycoprotein deficiency and macrocyclic lactone toxicity in an Australian Maine Coon cat homozygous for ABCB1 1930_1931del TC
Eprinomectin, one of the three active ingredients in NexGard Combo, is a macrocyclic lactone, a class of drugs that are known P-glycoprotein substrates. In a cat with defective P-glycoprotein, even a standard dose of a macrocyclic lactone can result in neurotoxicity, with signs ranging from disorientation and drooling to blindness, coma, and potentially death in severe cases.7Journal of Feline Medicine and Surgery Open Reports. Inherent P-glycoprotein deficiency and macrocyclic lactone toxicity in an Australian Maine Coon cat homozygous for ABCB1 1930_1931del TC
This mutation has been documented in certain breeds. The case report that identified the issue involved a Maine Coon, and the ABCB1 mutation is also well known in certain dog breeds like Collies and Australian Shepherds. In cats, the true prevalence of ABCB1 mutations across breeds has not been thoroughly mapped, so it is hard to say how many cats might be silently affected. Genetic testing is available and can identify carriers and homozygous animals. If you own a Maine Coon or another breed where this mutation has been suggested, asking your veterinarian about ABCB1 testing before using any macrocyclic lactone product is a reasonable precaution.
Safety During Pregnancy and Nursing
A dedicated reproductive safety study tested NexGard Combo in breeding female cats through mating, pregnancy, and lactation. The researchers reported no significant adverse reactions in either the mothers or the kittens, and no adverse effects on breeding parameters such as fertility, litter size, or kitten survival.8PubMed Central. Safety evaluation of a novel topical combination of esafoxolaner, eprinomectin and praziquantel, in reproducing female cats This is a more complete reproductive safety picture than many older parasite products offer, where pregnancy safety data is often limited or absent.
That said, “no significant adverse effects in one study” and “proven safe for all pregnant cats” are not quite the same thing. Any medication used during pregnancy carries some level of uncertainty, and individual cats may respond differently. Most veterinarians consider NexGard Combo reasonable to use in pregnant or nursing cats when parasite control is needed, but as always, the decision should involve your vet’s assessment of the specific situation.
Kittens and Minimum Weight Requirements
NexGard Combo is labeled for cats and kittens from eight weeks of age and weighing at least 0.8 kg (roughly 1.8 pounds). The weight threshold exists because very small animals are more sensitive to dosing variations, and the pharmacokinetics of the active ingredients may behave differently in underdeveloped bodies. Applying a product designed for a heavier cat to a kitten under the weight minimum increases the risk of overdose-related side effects, including the neurological effects described above.
If you have a kitten that is close to but not quite at the minimum weight, waiting a week or two until the kitten crosses the threshold is safer than guessing. Similarly, do not split a pipette intended for a larger cat between two kittens. The product comes in weight-banded pipettes for a reason, and dosing accuracy matters.
Practical Application Tips to Reduce Risk
Most of the avoidable problems with spot-on treatments come from application errors rather than the product itself. Applying the liquid to a spot the cat cannot easily reach and lick, typically the base of the skull, is standard practice. Part the fur until you can see skin, and apply the product directly to the skin rather than onto the hair. Let it dry before allowing contact with other pets, especially dogs that might groom the cat. While esafoxolaner is specifically formulated for cats, interspecies grooming can introduce unintended doses to other animals in the household.
Avoid bathing the cat or allowing heavy water exposure for at least 48 hours after application, as the product needs time to spread across the skin’s lipid layer. If you apply the product too low on the neck where the cat can reach it, you may see drooling or lip-licking, which is a taste reaction to the formulation rather than a true systemic side effect. It is unpleasant for the cat but generally harmless and short-lived.
One common mistake is applying a dog-specific isoxazoline product to a cat. Certain isoxazoline formulations approved for dogs contain different active ingredients or concentrations that are not safe for cats. NexGard Combo is specifically designed and dosed for feline physiology. The reverse is equally important: do not use a cat product on a dog, since the dosing and ingredient ratios differ.
Multi-Cat Households and Mutual Grooming
In homes with several cats, mutual grooming is an everyday behavior that creates a unique consideration for topical treatments. If one cat grooms the application site on another cat shortly after treatment, it may ingest some of the active ingredients. The amounts transferred through casual grooming are small and generally not enough to cause harm, but they could trigger drooling or mild gastrointestinal upset in the grooming cat. Separating cats for a few hours after application, or treating all cats on the same day so each has a drying period, can minimize this.
This concern becomes more serious if one of the cats in the household has a known seizure disorder or a suspected ABCB1 mutation. In that case, even small amounts of ingested macrocyclic lactone from grooming a housemate could pose a risk. Keeping the sensitive cat separated from treated cats until the product is fully absorbed is a worthwhile precaution.
How NexGard Combo Compares to Older Spot-On Products
Before NexGard Combo arrived, cat owners typically needed separate products to cover the full parasite spectrum: one for fleas and ticks, another for intestinal worms, and possibly a third for heartworm prevention. Each additional product meant another application, another set of potential side effects, and more room for drug interactions. The three-in-one design simplifies the routine and reduces total chemical exposure compared to stacking multiple products.
In the field study comparing NexGard Combo to Frontline Combo for cat louse infestations, both products performed well and neither caused adverse reactions in the treated cats over the monitoring period.5PubMed Central. Efficacy of a topical formulation containing esafoxolaner, eprinomectin and praziquantel (NexGard Combo®) against natural infestations with the cat louse, Felicola subrostratus under field conditions The advantage of NexGard Combo was not a safety difference in that study but the added coverage against internal parasites that the older product does not provide.
One practical consideration is cost. A product that replaces two or three individual treatments may cost more per pipette but can end up being less expensive overall than buying each component separately, depending on your region and pharmacy. Your vet can help you compare total monthly costs for the parasite coverage your cat actually needs based on lifestyle. An indoor-only cat in a low-heartworm-risk area may not need the full spectrum of protection that NexGard Combo provides, making a simpler and cheaper product perfectly adequate.
When to Talk to Your Vet Before Using It
For the average healthy adult cat, NexGard Combo has a well-supported safety profile and can be used with confidence. But a few situations call for a conversation with your veterinarian first:
- Seizure history: Any cat that has had seizures or a diagnosed neurological condition should be evaluated before starting an isoxazoline-containing product.
- Breed-related genetic risk: Maine Coons and potentially other breeds may carry the ABCB1 mutation that impairs macrocyclic lactone clearance. Genetic testing can clarify the risk.
- Very young or underweight kittens: Cats under eight weeks of age or below the minimum weight cutoff should not receive the product.
- Cats on other medications: Some drugs interact with P-glycoprotein pathways or compete for the same metabolic routes. If your cat is already on medication, your vet can check for interactions.
- Debilitated or chronically ill cats: The safety studies were conducted on healthy animals. Cats with severe kidney disease, liver disease, or other serious conditions may handle the drugs differently, and the risk-benefit calculus shifts.
None of these situations are absolute contraindications in every case. They are flags that the default answer of “safe for most cats” may not apply to your specific cat, and a veterinarian’s judgment is needed to weigh the parasite risk against the medication risk.